Neuroendocrine Tumors

Latest News

Data from a retrospective study suggests that stereotactic body radiotherapy may be a suitable alternative to surgical resection for patients with primary lung neuroendocrine tumors, according to an expert from Moffitt Cancer Center.

SBRT Provides Positive Locoregional Control in Lung Neuroendocrine Tumors

February 9th 2023

Data from a retrospective study suggests that stereotactic body radiotherapy may be a suitable alternative to surgical resection for patients with primary lung neuroendocrine tumors, according to an expert from Moffitt Cancer Center.

New Drug Application Complete for Surufatinib to Treat Pancreatic/Extra-Pancreatic NETs

By Audrey Sternberg

May 3rd 2021

Rolling submission with the FDA for surufatinib treatment in patients with pancreatic and extra-pancreatic neoendocrume tumors was completed and an expanded access program for the drug is currently underway for patients in the United States.

Adavosertib Plus Irinotecan Combination Met Efficacy End Point for Pediatric Neuroblastoma

By Matthew Fowler

April 13th 2021

Data presented at the virtual AACR Annual Meeting 2021 showed that a phase 2 trial examining combination treatment with adavosertib plus irinotecan met its protocol-defined efficacy end point in a cohort of pediatric patients with neuroblastoma.

Lymph Node Metastases, Additional Organ Resection Associated With Increased Recurrence Risk for PNETs

By Matthew Fowler

January 26th 2021

A study found a number of factors associated with increased recurrence risk for patients with locally advanced pancreatic neuroendocrine tumors following surgical resection, including sex, lymph node metastases, and resection of other organs with tumor involvement.

Pancreatic NETs Do Not Experience PFS Boost With Axitinib/Octreotide

By Tony Berberabe, MPH

January 19th 2021

No significant benefits to progression-free survival were noted with the axitinib-plus-octreotide combination for the treatment of patients with advanced G1-2 extra-pancreatic neuroendocrine tumors.

<1 2 3

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777